Medicinsk behandling af børn med infantile hæmangiomer

Infantile haemangioma is a benign vascular tumour seen in 4-5% of infants. It has a characteristic life cycle comprised by a proliferative phase and a spontaneous involution phase. Most infantile haemangiomas do not require intervention. Treatment is relevant when there is a risk of functional impairment or cosmetic disfigurement, or if the haemangiomas are painful and ulcerating. The beta blocker propranolol has been shown to be an excellent first-line treatment, and we present an algorithm for therapeutic decision and monitoring.